Courts Give Mixed Reviews To Preemption Policy In 2006 FDA Labeling Rule

Counsel’s Advisories

July 21, 2006

Appeals Court Ruling Embraces “PMA” Device Preemption

By Michael K. Brown is a partner, and Lisa M. Baird, partners in the international law firm of Reed Smith LLP who specialize in litigation involving the pharmaceutical and medical device industries.

Counsel’s Advisories

January 27, 2006

FDA Preempts “Failure-To-Warn” Pharmaceutical Liability Claims

By James Dabney Miller, a partner in the Washington, D.C. office of the law firm King & Spalding LLP.

Legal Backgrounders

February 25, 2005

FDA Position On Federal Preemption Consistent With Law And Public Health

By Eric G. Lasker, a partner in the Washington, D.C. law firm Spriggs & Hollingsworth.

In Op-Ed, WLF Advisory Board Member Questions FDA “Crackdown” on Pharma Ads

National Retail Federation v. James

A Threat to M&A Market Vitality: “Break-Up Fee” Taxation in the Pending Appeal of AbbVie v. Comm. of Internal Revenue

Working Papers

Courts Give Mixed Reviews To Preemption Policy In 2006 FDA Labeling Rule

Appeals Court Ruling Embraces “PMA” Device Preemption

FDA Preempts “Failure-To-Warn” Pharmaceutical Liability Claims

FDA Position On Federal Preemption Consistent With Law And Public Health

Featured

In Op-Ed, WLF Advisory Board Member Questions FDA “Crackdown” on Pharma Ads

Featured Case

National Retail Federation v. James

Featured

A Threat to M&A Market Vitality: “Break-Up Fee” Taxation in the Pending Appeal of AbbVie v. Comm. of Internal Revenue

Working Papers

Courts Give Mixed Reviews To Preemption Policy In 2006 FDA Labeling Rule

Related Content

Appeals Court Ruling Embraces “PMA” Device Preemption

FDA Preempts “Failure-To-Warn” Pharmaceutical Liability Claims

FDA Position On Federal Preemption Consistent With Law And Public Health